Rapid Micro Biosystems, Inc.
General ticker "RPID" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $114.6M (TTM average)
Rapid Micro Biosystems, Inc. follows the US Stock Market performance with the rate: 37.2%.
Estimated limits based on current volatility of 1.5%: low 3.99$, high 4.12$
Factors to consider:
- Total employees count: 163 (-15.5%) as of 2024
- US accounted for 37.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Growth challenges, Marketing effectiveness, Labor/talent shortage/retention, Cybersecurity threats, Geopolitical risks
- Current price 135.1% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.64$, 1.71$]
- 2025-12-31 to 2026-12-31 estimated range: [0.56$, 1.53$]
Financial Metrics affecting the RPID estimates:
- Positive: with PPE of -0.9 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -108.73 <= 0.33
- Positive: Investing cash flow per share per price, % of 90.27 > -0.66
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of -5.66 <= -0.75
- Negative: negative Net income
Short-term RPID quotes
Long-term RPID plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $17.13MM | $22.52MM | $28.05MM |
| Operating Expenses | $80.35MM | $79.08MM | $77.97MM |
| Operating Income | $-63.22MM | $-56.56MM | $-49.92MM |
| Non-Operating Income | $1.84MM | $4.13MM | $3.05MM |
| R&D Expense | $12.87MM | $12.82MM | $14.60MM |
| Income(Loss) | $-61.38MM | $-52.44MM | $-46.87MM |
| Taxes | $-0.58MM | $0.03MM | $0.02MM |
| Profit(Loss)* | $-60.81MM | $-52.47MM | $-46.89MM |
| Stockholders Equity | $164.17MM | $117.99MM | $75.35MM |
| Inventory | $21.19MM | $19.96MM | $20.20MM |
| Assets | $190.65MM | $143.45MM | $98.17MM |
| Operating Cash Flow | $-58.55MM | $-45.08MM | $-44.15MM |
| Capital expenditure | $6.74MM | $1.84MM | $1.36MM |
| Investing Cash Flow | $-93.47MM | $42.15MM | $36.66MM |
| Financing Cash Flow | $0.69MM | $0.15MM | $0.20MM |
| Earnings Per Share** | $-1.43 | $-1.22 | $-1.08 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.